ZA913282B - Dosage form - Google Patents
Dosage formInfo
- Publication number
- ZA913282B ZA913282B ZA913282A ZA913282A ZA913282B ZA 913282 B ZA913282 B ZA 913282B ZA 913282 A ZA913282 A ZA 913282A ZA 913282 A ZA913282 A ZA 913282A ZA 913282 B ZA913282 B ZA 913282B
- Authority
- ZA
- South Africa
- Prior art keywords
- dosage form
- parkinson
- disease
- administering
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/520,295 US5190763A (en) | 1990-05-07 | 1990-05-07 | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA913282B true ZA913282B (en) | 1992-02-26 |
Family
ID=24071988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA913282A ZA913282B (en) | 1990-05-07 | 1991-04-30 | Dosage form |
Country Status (17)
Country | Link |
---|---|
US (1) | US5190763A (es) |
EP (1) | EP0527835B1 (es) |
JP (1) | JP2634322B2 (es) |
KR (1) | KR0169146B1 (es) |
AT (1) | ATE113203T1 (es) |
AU (1) | AU641770B2 (es) |
CA (1) | CA2041579C (es) |
DE (1) | DE69104830T2 (es) |
DK (1) | DK0527835T3 (es) |
ES (1) | ES2067231T3 (es) |
FI (1) | FI925029A0 (es) |
IE (1) | IE62397B1 (es) |
NO (1) | NO924209L (es) |
NZ (2) | NZ238011A (es) |
PT (1) | PT97552B (es) |
WO (1) | WO1991016885A1 (es) |
ZA (1) | ZA913282B (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221536A (en) * | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
SE9301112D0 (sv) * | 1993-04-02 | 1993-04-02 | Orion-Yhtymae Oy | A new composition |
US5369120A (en) * | 1993-07-28 | 1994-11-29 | Warner-Lambert Company | Pharmaceutical composition of 7-((substituted)amino-8-((substituted)carbonyl)-(methylamino)-1-oxasp iro(4,5)decanes and L-dopa |
IL112106A0 (en) * | 1993-12-22 | 1995-03-15 | Ergo Science Inc | Accelerated release composition containing bromocriptine |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
US20040191314A1 (en) * | 1994-04-28 | 2004-09-30 | Frank Jao | Antiepileptic dosage form and process for protecting antiepileptic drug |
US20030056896A1 (en) * | 1995-05-12 | 2003-03-27 | Frank Jao | Effective therapy for epilepsies |
US6319954B1 (en) | 1995-01-13 | 2001-11-20 | Somerset Pharmaceuticals, Inc. | S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions |
US6299901B1 (en) | 1995-01-13 | 2001-10-09 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6348208B1 (en) * | 1995-01-13 | 2002-02-19 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6033682A (en) * | 1995-01-13 | 2000-03-07 | Somerset Pharmaceuticals, Inc. | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
WO1996040085A2 (en) * | 1995-06-07 | 1996-12-19 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
DE19626621A1 (de) * | 1996-07-02 | 1998-01-08 | Hexal Ag | Pflaster zur transdermalen Anwendung von Pergolid |
US6623752B1 (en) | 1996-07-02 | 2003-09-23 | Hexal Ag | Patch for transdermal application for pergolid |
US7179486B1 (en) | 1997-04-01 | 2007-02-20 | Nostrum Pharmaceuticals, Inc. | Process for preparing sustained release tablets |
DE69902520T2 (de) | 1998-03-16 | 2003-04-10 | Somerset Pharmaceuticals, Inc. | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden |
DE19855704C2 (de) * | 1998-12-03 | 2002-08-01 | Lothar Saiger | Verwendung einer Wirkstoffkombination zur Behandlung der Parkinsonschen Krankheit |
JP4100910B2 (ja) * | 1999-12-23 | 2008-06-11 | ファイザー・プロダクツ・インク | ヒドロゲル駆動の薬物剤形 |
CA2395231C (en) | 1999-12-23 | 2006-08-15 | Pfizer Products Inc. | Hydrogel-driven layered drug dosage form |
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
US6531153B2 (en) * | 2001-05-29 | 2003-03-11 | Drugtech Corporation | Composition with sustained release of levodopa and carbidopa |
CA2463987C (en) * | 2001-11-05 | 2011-03-08 | Seth Lederman | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
EP1496868A1 (en) * | 2002-04-11 | 2005-01-19 | Ranbaxy Laboratories, Ltd. | Controlled release pharmaceutical compositions of carbidopa and levodopa |
JP2006524708A (ja) * | 2003-04-25 | 2006-11-02 | インディヴァス ファーマシューティカルズ,インコーポレーテッド | 塩化トロスピウムの投与により連続睡眠を促進するための方法 |
WO2004112756A1 (en) * | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US20050070608A1 (en) * | 2003-08-29 | 2005-03-31 | Julius Remenar | Pharmaceutical compositions and method of using levodopa and carbidopa |
US8815950B2 (en) | 2003-08-29 | 2014-08-26 | Janssen Biotech, Inc. | Pharmaceutical compositions and method of using levodopa and carbidopa |
WO2005072705A1 (en) * | 2004-01-29 | 2005-08-11 | Neuromolecular, Inc. | Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions |
JP2005309912A (ja) * | 2004-04-23 | 2005-11-04 | Oki Data Corp | 画像形成装置 |
US7323585B2 (en) * | 2004-06-04 | 2008-01-29 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
JP4781352B2 (ja) * | 2004-06-04 | 2011-09-28 | ゼノポート,インコーポレーテッド | レボドパプロドラッグおよびその組成物ならびにその使用 |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) * | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US7619007B2 (en) * | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
EP1845968A2 (en) * | 2004-11-24 | 2007-10-24 | Neuromolecular Pharmaceuticals, Inc | Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
US8252331B2 (en) * | 2004-12-03 | 2012-08-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Osmotic device containing amantadine and an osmotic salt |
AR053986A1 (es) | 2004-12-03 | 2007-05-30 | Osmotica Pharmaceutical Argent | Dispositivo osmotico que contiene amantadina y una sal osmotica |
US8574626B2 (en) | 2004-12-03 | 2013-11-05 | Osmotica Kereskedelmi és Szolgáltató KFT | Osmotic device containing amantadine and an osmotic salt |
EP1874353A1 (en) | 2005-04-05 | 2008-01-09 | Yale University | Glutamate modulating agents in the treatment of mental disorders |
MX2007012374A (es) | 2005-04-06 | 2008-02-22 | Adamas Pharmaceuticals Inc | Metodos y composiciones para el tratamiento de condiciones relacionadas con cns. |
US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
ES2391575T3 (es) | 2005-12-05 | 2012-11-27 | Xenoport, Inc. | Mesilato de profármaco de Levodopa, sus composiciones y sus usos |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
DE602006018529D1 (de) * | 2005-12-29 | 2011-01-05 | Osmotica Kereskedelmi Es Szolgaltato Kft | Mehrschichtige tablette mit dreifacher freisetzungskombination |
US9561188B2 (en) * | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
PE20080669A1 (es) * | 2006-09-08 | 2008-07-18 | Drugtech Corp | Composicion de liberacion sostenida que comprende levodopa |
WO2008079387A1 (en) * | 2006-12-21 | 2008-07-03 | Xenoport, Inc. | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
CA2673336A1 (en) | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
AU2007338631A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
NZ590291A (en) * | 2008-06-06 | 2013-11-29 | Pharma Two B Ltd | Pharmaceutical compositions for treatment of parkinson's disease |
US8399513B2 (en) * | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
JP2012505885A (ja) * | 2008-10-20 | 2012-03-08 | ゼノポート,インコーポレーテッド | レボドパエステルプロドラッグを合成する方法 |
CA2792484C (en) * | 2009-03-12 | 2017-10-31 | Delpor, Inc. | Implantable device for long-term delivery of drugs |
AU2010315892B2 (en) | 2009-11-09 | 2014-09-18 | Xenoport, Inc. | Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
CA2782556C (en) | 2009-12-02 | 2018-03-27 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
CN111372578A (zh) | 2017-08-24 | 2020-07-03 | 阿达玛斯药物有限责任公司 | 金刚烷胺组合物、其制备和使用方法 |
US10213393B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság | Composition and method for treating neurological disease |
US10213394B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US20190247331A1 (en) | 2018-02-15 | 2019-08-15 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4058122A (en) * | 1976-02-02 | 1977-11-15 | Alza Corporation | Osmotic system with laminated wall formed of different materials |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4522625A (en) * | 1982-09-29 | 1985-06-11 | Alza Corporation | Drug dispenser comprising wall formed of semipermeable member and enteric member |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
NZ206600A (en) * | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
US4743247A (en) * | 1984-08-13 | 1988-05-10 | Alza Corporation | Process for manufacturing dosage form |
US4716496A (en) * | 1986-05-09 | 1987-12-29 | Eaton Corporation | Panel-mounted control station housing |
US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
-
1990
- 1990-05-07 US US07/520,295 patent/US5190763A/en not_active Expired - Lifetime
-
1991
- 1991-04-30 ZA ZA913282A patent/ZA913282B/xx unknown
- 1991-05-01 ES ES91908910T patent/ES2067231T3/es not_active Expired - Lifetime
- 1991-05-01 AT AT91908910T patent/ATE113203T1/de not_active IP Right Cessation
- 1991-05-01 KR KR1019920702752A patent/KR0169146B1/ko not_active IP Right Cessation
- 1991-05-01 NZ NZ238011A patent/NZ238011A/en unknown
- 1991-05-01 JP JP3508898A patent/JP2634322B2/ja not_active Expired - Lifetime
- 1991-05-01 DK DK91908910.2T patent/DK0527835T3/da active
- 1991-05-01 IE IE146691A patent/IE62397B1/en not_active IP Right Cessation
- 1991-05-01 EP EP91908910A patent/EP0527835B1/en not_active Expired - Lifetime
- 1991-05-01 NZ NZ248491A patent/NZ248491A/en unknown
- 1991-05-01 CA CA002041579A patent/CA2041579C/en not_active Expired - Lifetime
- 1991-05-01 WO PCT/US1991/002995 patent/WO1991016885A1/en active IP Right Grant
- 1991-05-01 DE DE69104830T patent/DE69104830T2/de not_active Expired - Fee Related
- 1991-05-01 AU AU78543/91A patent/AU641770B2/en not_active Ceased
- 1991-05-02 PT PT97552A patent/PT97552B/pt not_active IP Right Cessation
-
1992
- 1992-11-02 NO NO92924209A patent/NO924209L/no unknown
- 1992-11-06 FI FI925029A patent/FI925029A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
FI925029A (fi) | 1992-11-06 |
US5190763A (en) | 1993-03-02 |
IE911466A1 (en) | 1991-11-20 |
CA2041579C (en) | 2003-09-30 |
JP2634322B2 (ja) | 1997-07-23 |
KR0169146B1 (ko) | 1999-01-15 |
AU641770B2 (en) | 1993-09-30 |
KR930700076A (ko) | 1993-03-13 |
PT97552A (pt) | 1992-01-31 |
CA2041579A1 (en) | 1991-11-08 |
NO924209D0 (no) | 1992-11-02 |
AU7854391A (en) | 1991-11-27 |
JPH05506858A (ja) | 1993-10-07 |
FI925029A0 (fi) | 1992-11-06 |
WO1991016885A1 (en) | 1991-11-14 |
ES2067231T3 (es) | 1995-03-16 |
DE69104830T2 (de) | 1995-03-02 |
IE62397B1 (en) | 1995-01-25 |
EP0527835B1 (en) | 1994-10-26 |
EP0527835A1 (en) | 1993-02-24 |
DE69104830D1 (de) | 1994-12-01 |
ATE113203T1 (de) | 1994-11-15 |
NZ248491A (en) | 1995-12-21 |
NZ238011A (en) | 1995-12-21 |
NO924209L (no) | 1992-11-09 |
PT97552B (pt) | 1998-08-31 |
DK0527835T3 (da) | 1995-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA913282B (en) | Dosage form | |
GR900100659A (en) | Dosage form for administering oral hupoglycemic glipizide | |
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
EP0377520A3 (en) | Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment | |
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
EP0552256A4 (es) | ||
HU883863D0 (en) | Process for the preparation of producing and/or portionly form of therapeutical agents | |
IL112288A (en) | Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases | |
GR3018365T3 (en) | Use of 15-deoxyspergualine as a medicament. | |
SE8804640L (sv) | Laekemedel omfattande cyklolinopeptide a | |
GR3022608T3 (en) | USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE. | |
SE9101341D0 (sv) | New medicinal use | |
GB2019720A (en) | S-adenosyl-L-homocysteine and salts thereof for use in therapy | |
SE9704451D0 (sv) | New method and compositions for the treatment of autoimmune diseases | |
IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
RU94020964A (ru) | Электростатический пластырь "элпласт" | |
RU93058154A (ru) | Способ лечения ранних приобретенных форм сифилиса | |
IT1243947B (it) | 2-azido-ornitina, sua preparazione e suo impiego in terapia |